Abcellera

1 trends tracked about this subject — the full history, oldest to newest below.

↑ Rising Business

AbCellera shares surged after Phase 2 trial results for ABCL635 showed an 83% reduction in menopause-related hot flashes.

7 sources 8 articles v 26 54m ago